RT Book, Section A1 Arumugam, Parthiban A1 Memmott, Matthew A1 Heller, Gary V. A2 Heller, Gary V. A2 Bateman, Timothy M. A2 Case, James A. A2 Arumugam, Parthiban SR Print(0) ID 1159184551 T1 Clinical Overview of Contemporary Myocardial Perfusion Imaging with Cardiac Positron Emission Tomography (PET) T2 Cardiovascular PET: Current Concepts YR 2019 FD 2019 PB McGraw-Hill Education PP New York, NY SN 9781259860485 LK accesscardiology.mhmedical.com/content.aspx?aid=1159184551 RD 2024/03/29 AB Cardiac PET myocardial perfusion imaging has gained considerable acceptance in the clinical world of Nuclear Cardiology for many reasons. One driving force has been the substantial expansion of PET oncology, which has led to widespread availability of PET scanners in hospital settings. However, the burgeoning literature has also provided a demonstration of the incremental clinical value of cardiac PET, which has resonated in the marketplace and resulted in a gradual but steady growth of this modality into office-based and hospital settings. Finally, the sustained availability of radiotracers in the form of generator-produced 82Rb and cyclotron-produced 13N-ammonia has provided a stable milieu for the growth of cardiac PET myocardial perfusion imaging. This chapter describes the latest documentation of the important aspects of cardiac PET that makes this a compelling story for the present and future of nuclear cardiology. Sections include: brief history of cardiac PET, description of available tracers, diagnostic accuracy, image quality, unique aspects of PET MPI data, including myocardial blood flow (MBF), risk stratification, radiation exposure, protocols, and patients best suited for evaluation and tracers in development.